Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant <i>Pseudomonas aeruginosa</i> and Minimize Biofilm Formation

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant <i>Pseudomonas aeruginosa</i> and Minimize Biofilm Formation

The emergence of antibiotic resistance has severely impaired the treatment of chronic respiratory infections caused by multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i>. Since the reintroduction of polymyxins as a last-line therapy against MDR Gram-negative bacteria, resistance to...

Full description

Bibliographic Details
Main Authors:	Hasini Wickremasinghe, Heidi H. Yu, Mohammad A. K. Azad, Jinxin Zhao, Phillip J. Bergen, Tony Velkov, Qi Tony Zhou, Yan Zhu, Jian Li
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Antibiotics
Subjects:	polymyxin meropenem combination therapy multidrug resistance <i>Pseudomonas aeruginosa</i> synergy
Online Access:	https://www.mdpi.com/2079-6382/10/4/405

Similar Items

Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens
by: Thien B. Tran, et al.
Published: (2018-04-01)

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
by: Thien B. Tran, et al.
Published: (2018-04-01)

In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, blaNDM-1 and blaKPC-2
by: Elza Ferreira Firmo, et al.
Published: (2020-09-01)

<em>IN VITRO</em> ACTIVITY OF POLYMYXIN B AND MEROPENEM ALONE AND IN COMBINATION AGAINST CARBAPENEM-RESISTANT ENTEROBACTERIACEAE
by: Kulengowski, Brandon T.
Published: (2016)

A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii
by: Mohammed Ali M.Marie, et al.
Published: (2015-10-01)

Molecular Analysis of Polymyxin Resistance among Carbapenemase-Producing <i>Klebsiella pneumoniae </i>in Colombia
by: Elsa De La Cadena, et al.
Published: (2021-03-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
by: Jiang Z, et al.
Published: (2018-08-01)

Non-clonal occurrence of pmrB mutations associated with polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae in Brazil
by: Ana Claudia Souza Rodrigues, et al.
Published: (2019-05-01)

Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive <i>Enterobacteriaceae</i> in vitro
by: Yanling Wang, et al.
Published: (2020-03-01)

Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
by: Li Liu, et al.
Published: (2020-10-01)

Bi-Functional Alginate Oligosaccharide–Polymyxin Conjugates for Improved Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections
by: Joana Stokniene, et al.
Published: (2020-11-01)

Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
by: Yu-Wei Lin, et al.
Published: (2019-10-01)

Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?
by: Silvia Corcione, et al.
Published: (2020-03-01)

Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa
by: Mei-Ling Han, et al.
Published: (2019-01-01)

Design and Evaluation of Novel Polymyxin Fluorescent Probes
by: Bo Yun, et al.
Published: (2017-11-01)

Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumannii
by: Mei-Ling Han, et al.
Published: (2018-11-01)

Emergence of polymyxin B-resistant Acinetobacter baumannii in hospitals in Rio de Janeiro
by: Gabrielle L. Genteluci, et al.

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter baumannii
by: Mei-Ling Han, et al.
Published: (2019-07-01)

Colistin Dependence in Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Strain Is Associated with IS<i>Ajo2</i> and IS<i>Aba13</i> Insertions and Multiple Cellular Responses
by: Sherley Chamoun, et al.
Published: (2021-01-01)

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance
by: Yan Zhu, et al.
Published: (2020-08-01)

Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance
by: Carole Ayoub Moubareck
Published: (2020-08-01)

Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation
by: Xiangqing Song, et al.
Published: (2019-11-01)

The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii
by: Wasan Katip, et al.
Published: (2020-08-01)

Review of the international consensus guidelines for the optimal use of the polymyxins
by: Eliseeva E.V., et al.
Published: (2019-12-01)

Identification of Novel PhoP-PhoQ Regulated Genes That Contribute to Polymyxin B Tolerance in <i>Pseudomonas aeruginosa</i>
by: Baopeng Yang, et al.
Published: (2021-02-01)

Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling
by: Yan Zhu, et al.
Published: (2019-02-01)

Polymyxins–Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment
by: Chongshan Dai, et al.
Published: (2020-06-01)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
by: Dongna Zou, et al.
Published: (2021-04-01)

An Update on the arsenal for multidrug-resistant Acinetobacter infections: Polymyxin antibiotics
by: Zahra Kassamali, et al.
Published: (2015-01-01)

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
by: Wei Guo, et al.
Published: (2018-02-01)

Appropriate Use of Meropenem: A Pharmacy Intervention
by: Stacey Abbott, et al.
Published: (2014)

Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant <i>Klebsiella pneumoniae</i> Pneumonia–Septicemia Model in Rats
by: Hessel Van der Weide, et al.
Published: (2020-03-01)

Shifting Gears: The Future of Polymyxin Antibiotics
by: Justin R. Lenhard, et al.
Published: (2019-04-01)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01)

Meropenem: A possible new culprit in eosinophilic lung diseases
by: Nathalie Abi Hatem, et al.
Published: (2017-01-01)

Clinical Pharmacology of Meropenem in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici
Published: (2016-11-01)

In vitro polymyxin activity against clinical multidrug-resistant fungi
by: Hanane Yousfi, et al.
Published: (2019-04-01)

Synergistic Killing and Re-Sensitization of <i>Pseudomonas aeruginosa</i> to Antibiotics by Phage-Antibiotic Combination Treatment
by: Emily Engeman, et al.
Published: (2021-02-01)

A Review of the Clinical Pharmacokinetics of Polymyxin B
by: Sean N. Avedissian, et al.
Published: (2019-03-01)